Chloroquinoxaline sulfonamide

E3 Ligase: Chloroquinoxaline sulfonamide (CQS) recruits the DCAF15 E3 ligase complex, facilitating targeted ubiquitination of neosubstrate proteins. This recruitment stabilizes the formation of the ternary complex, enabling selective engagement for degradation.

Target Protein: The primary target of CQS is RBM39, an RNA-binding protein involved in pre-mRNA splicing. By engaging RBM39, CQS disrupts RNA processing and transcriptional regulation in cells.

Degradation Mechanism: CQS mediates proteasomal degradation of RBM39 via the ubiquitin–proteasome system. The DCAF15–RBM39 ternary complex promotes polyubiquitination, marking the protein for recognition and clearance by the 26S proteasome, leading to efficient depletion of RBM39.

• Molecular Glue for Protein Degradation: Chloroquinoxaline sulfonamide acts as a molecular glue, facilitating targeted protein degradation by enhancing the interaction between E3 ubiquitin ligases and specific protein substrates. This mechanism allows researchers to selectively degrade proteins of interest, offering a powerful tool for studying protein function and regulation in cellular processes.

• Targeted Degradation in Cancer Research: By promoting the selective degradation of oncogenic proteins, Chloroquinoxaline sulfonamide serves as a valuable asset in cancer research. It aids in the exploration of novel therapeutic strategies aimed at dismantling the protein networks that sustain tumor growth and survival, thereby advancing our understanding of cancer biology.

• Enhancing Protein-Protein Interactions: The ability of Chloroquinoxaline sulfonamide to modulate protein-protein interactions makes it an essential tool in studying complex cellular pathways. Researchers can utilize this compound to investigate the dynamics of protein complexes and their roles in cellular signaling and homeostasis, providing insights into molecular mechanisms underlying various diseases.

• Advancing Drug Discovery: Chloroquinoxaline sulfonamide's role in targeted protein degradation positions it as a pivotal component in drug discovery efforts. By enabling the identification and validation of novel drug targets, it supports the development of innovative therapeutic agents that can selectively modulate disease-associated proteins.